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Abstract
Introduction: There is a growing amount of evidence showing the significant analytical bias of steroid hormone immunoassays, but large num-
ber of available immunoassays makes conduction of a single comprehensive study of this issue hardly feasible. Aim of this study was to assess 
the analytical bias of six heterogeneous immunoassays for serum aldosterone, cortisol, dehydroepiandrosterone sulphate (DHEAS), testosterone, 
17-hydroxyprogesterone (OHP) and progesterone using the liquid chromatography coupled to the tandem mass spectrometry (LC-MS/MS).
Materials and methods: This method comparison study included 49 serum samples. Testosterone, DHEAS, progesterone and cortisol immunoa-
ssays were performed on the Abbott Architect i2000SR or Alinity i analysers (Abbott Diagnostics, Chicago, USA). DiaSorin’s Liaison (DiaSorin, Salu-
ggia, Italy) and DIAsource’s ETI-Max 3000 analysers (DIAsource ImmunoAssays, Louvain-La-Neuve, Belgium) were chosen for aldosterone and OHP 
immunoassay testing, respectively. All immunoassays were evaluated against the LC-MS/MS assay relying on the commercial kit (Chromsystems, 
Gräfelfing, Germany) and LCMS-8050 analyser (Shimadzu, Kyoto, Japan). Analytical biases were calculated and method comparison was conducted 
using weighted Deming regression analysis.
Results: Depending on the analyte and specific immunoassay, mean relative biases ranged from -31 to + 137%. Except for the cortisol, immu-
noassays were positively biased. For none of the selected steroids slope and intercept 95% confidence intervals simultaneously contained 0 and 1, 
respectively.
Conclusions: Evaluated immunoassays failed to satisfy requirements for methods’ comparability and produced significant analytical biases in res-
pect to the LC-MS/MS assay, especially at low concentrations.
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Introduction
Immunoassays are widely used for quantification 
of different serum steroid hormones. This analyti-
cal approach can be easily automated which, in 
turn, reduces the turn-around-time and staff re-
quirements. As such, serum steroid immunoassays 
are especially suitable for the diagnostic workup 
of patients coming to emergency rooms. However, 
over the last few decades’ awareness about the 
flaws of immunoassays for quantification of bio-
molecules is growing (1). While the immunoassays 
for protein quantifications are prone to different 
https://doi.org/10.11613/BM.2020.030701 Biochem Med (Zagreb) 2020;30(3):030701 
  1
types of interferences, immunoassays intended for 
determinations of small biomolecules like steroids 
are affected primarily by the lack of selectivity 
(2,3). Common interfering molecules in immuno-
assays are metabolites and drugs (3). In the classi-
cal congenital adrenal hyperplasia (CAH), falsely 
elevated cortisol may be due to the cross-reactivi-
ty with 21-deoxycortisol, while in the pregnancy 
pregnenolone sulphate interferes with the dehy-
droepiandrosterone sulphate (DHEAS) measure-
ment. Falsely elevated cortisol may be encoun-
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tered during the hypoadrenalism treatment with 
prednisolone or 6-metylprednisolone. Also, estra-
diol immunoassays may show striking method-
specific bias in lower serum concentration range, 
for example in aromatase-inhibitor treated wom-
en (2).
Antibodies mostly do not have strong affinity for 
small molecules such as steroid hormones and the 
differences between the small structurally related 
molecules having different biological roles cannot 
be safely discerned using antibodies (4,5). Numer-
ous endogenous and exogenous compounds 
sharing the same sterane scaffold may exist in se-
rum or other biological fluids and some of them 
may even have the same empirical formula. Similar 
functional groups and short side chains attached 
to the sterane positions that are in close proximity 
can be hardly recognized by the macromolecular 
structures like antibodies (5).
This lack of selectivity reflects itself on quantifica-
tion accuracy, which causes the analytical bias. 
First reports on steroid immunoassays bias date 
back to late 1990’s (1). In these cases, the bias has 
been assessed using mostly gas chromatography 
– mass spectrometry (GC-MS). Problems with the 
analytical bias of serum immunoassays for steroid 
quantification still persist: there is a long-lasting 
demand for more accurate methods and tech-
niques that are less complex in terms of manual 
sample preparation than GC-MS (1-5). Techniques 
like the liquid chromatography – tandem mass 
spectrometry (LC-MS/MS) with electrospray ioni-
zation source are better suited for the analysis of 
steroid hormones in body fluids (6). Multiple reac-
tion monitoring (MRM) mode of tandem mass 
spectrometry (MS) combined with the chromato-
graphic separation of different serum components 
significantly improves the analytical selectivity re-
quired for differentiation between closely struc-
turally related steroids. Moreover, visual presenta-
tion of results in the form of chromatogram allows 
the analyst to detect possible interferences. De-
tection and even elimination of possible problem 
associated with interferences can be achieved us-
ing different MRM channels for the same com-
pound (5,6). Multiple reaction monitoring also en-
ables application of the isotopically labelled inter-
nal standards (ISTD), which improves the accuracy 
even more. All these properties of the LC-MS/MS 
technology make it reliable reference against 
which the analytical bias of less selective analytical 
techniques may be assessed.
Due to the vast number of steroids and ever-
emerging immunoassays, most of the assays avail-
able on the market have not been sufficiently eval-
uated utilizing more selective techniques like iso-
tope dilution mass spectrometry and/or LC-MS/MS. 
This is the case even for the frequently utilized ster-
oid assays (7,8). Moreover, the majority of existing 
studies of analytical bias were focused on a single 
steroid hormone and a single immunoassay: there 
is a need for more elaborate approach to the prob-
lem covering different immunoassays and different 
steroid hormones which will enable some general 
conclusions to be drawn (6-8). The aim of this study 
is to analyse the analytical bias of heterogeneous 
immunoassays for six serum steroid hormones 
against the validated and commercially available 
LC-MS/MS assay. The LC-MS/MS assay enables mul-
tiplex quantification of serum steroids, among 
which aldosterone, cortisol, DHEAS, testosterone, 
17-hydroxyprogesterone (OHP) and progesterone 
were selected for the analytical bias evaluation. Au-
tomated heterogeneous immunoassays, that is 
sandwich ELISA assay, chemiluminescent micropar-
ticle immunoassay (CMIA) and chemiluminescent 
immunoassay (CLIA) were evaluated in this study. 
This particular immunoassay and analyser platform 
selection reflects the need for accomplishment of 
maximum possible diversity of evaluated immuno-
assays which is the prerequisite for reaching gen-
eral conclusions. Among steroid hormones fre-
quently measured in both clinical and research set-
tings, only the estradiol was omitted due to reports 
stating that, under certain circumstances, even the 
LC-MS/MS assay for estradiol quantification may be 
prone to interferences (2).
Materials and methods
Subjects 
This method comparison study was conducted at 
the Clinical Institute of Laboratory Diagnostics, 
Osijek University Hospital, Croatia from September 
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to December 2018 in accordance with the Declara-
tion of Helsinki. The study was approved by the 
Hospital’s Ethical Committee. Patients being rou-
tinely evaluated for the serum steroid hormone 
status were enrolled in the study (N = 65): this was 
the sole inclusion criterion. The preliminary diag-
noses of enrolled patients consisting of 37 females 
aged 32 (19–45) and 12 males aged 37 (27–62) 
were postulated by a physician as: female and 
male infertility, testicular and ovarian disorder, pol-
ycystic ovary syndrome, amenorrhea, acne and 
benign adrenal neoplasm. One sample per patient 
has been analysed by all immunoassays and by 
the LC-MS/MS assay. Due to the following exclu-
sion criteria: insufficient sample volume, haemoly-
sis, lipemia or icterus 15 samples were excluded. A 
total of 49 samples were used for the evaluation, 
which is in accordance with CLSI EP09-A3 guide-
lines: Measurement Procedure Comparison and 
Bias Estimation Using Patient Samples (3rd edition). 
After an overnight fasting, one blood sample per 
each enrolled patient was drawn from the antecu-
bital vein. The sampling was done between 7 and 9 
hours a.m. in 7 mL tubes containing no anticoagu-
lant or gel separator (Becton Dickinson, Franklin 
Lakes, USA), where upon they were left in the up-
right position for 30 minutes before centrifugation 
at 2000xg for 10 minutes at room temperature us-
ing 3-16PK centrifuge (Sigma Laborzentrifugen, Os-
terode am Harz, Germany). Each serum was sepa-
rated from the clot, divided into 600 µL aliquots and 
stored at - 18°C up to one month until the analysis.
Methods
Samples for the multiplex LC-MS/MS analysis of al-
dosterone, cortisol, testosterone, DHEAS, proges-
terone and OHP were prepared according to the 
kit manufacturer’s instructions (Chromsystems, 
Gräfelfing, Germany). Prepared samples were ana-
lysed using Nexera X2 liquid chromatograph cou-
pled with Shimadzu LCMS-8050 tandem mass 
spectrometer (Shimadzu, Kyoto, Japan) equipped 
with the electrospray ionization source. According 
to the LC-MS/MS kit manufacturer’s instructions, 
analyses were conducted using two different in-
strumental settings and two different sets of cali-
brators and controls, which is two different panels. 
The first panel was intended for the aldosterone 
and cortisol determinations and the second was 
intended for the DHEAS, testosterone, progester-
one and OHP determinations. Both panels shared 
the same sample preparation steps and the same 
instrumentation. All calibrators were traceable to 
certified reference materials and primary stand-
ards. For each analyte the kit manufacturer provid-
ed corresponding isotopically labelled ISTD and at 
least two MRM channels for each analyte and cor-
responding ISTD. Implementation of the kit on the 
LC-MS/MS instrument used in this study has been 
done by the manufacturer’s application specialist: 
all chromatography settings and all MS/MS set-
tings were implemented according to the recom-
mendations specific for the LC-MS/MS instrument 
used in this study. Mass transitions tuning has 
been done using tuning mixes provided by the 
manufacturer. Method validation data obtained 
on two different LC-MS/MS instruments provided 
by the manufacturer are summarized in Table 1. 
Testosterone, DHEAS and cortisol immunoassays 
were performed using commercially available Ab-
bott CMIA kits implemented on the Abbott Archi-
tect i2000SR, while progesterone immunoassay 
was performed on Abbott Architect i2000SR and 
Abbott Alinity i automatic analysers (Abbott Diag-
nostics, Chicago, USA). Aldosterone concentration 
was measured using CLIA method implemented on 
DiaSorin Liaison automatic analyser (DiaSorin, 
Saluggia, Italy), while OHP concentration was deter-
mined by DIAsource sandwich ELISA method (DIA-
source ImmunoAssays, Louvain-La-Neuve, Belgium) 
implemented on the ETI-Max 3000 (DiaSorin, Salug-
gia, Italy). Manufacturers provided calibrators, inter-
nal control materials and method validation reports 
(Table 2) for all commercially available kits. All im-
munoassay calibrators were traceable to primary 
standards and certified reference materials. 
For all analytes and assays, internal quality control 
provided by each manufacturer has been per-
formed as a part of every analytical sequence, 
while the external quality control evaluation of all 
analytes has been carried out on a monthly basis 
using Randox Riqas Monthly Immunoassay 
scheme (Randox, Crumlin, UK). Internal quality 
control material for the LC-MS/MS assay included 5 
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Analyte, unit
(polarity: MRM1; MRM2)
Reagent/
Manufacturer Assay range
Limit of
quantification
Inter-assay
precision, CV% Recovery, %
Aldosterone, nmol/L
(- :359→331;359→189)
MassChrom Steroids in 
Serum and Plasma/
Chromsystems
0.039–16.62 0.039 5.9% 95%
Cortisol, µmol/L
(+ :363→97;363→121) 0.004–1.44 0.004 5.0% 93%
DHEAS, µmol/L
(- :369→99;369→82) 0.066–48.78 0.066 6.9% 90%
Testosterone, nmol/L
(+ :289→97;289→109) 0.02–83.28 0.02 8.9% 95%
Progesterone, nmol/L
(+ :315→97;315→109) 0.095–79.5 0.095 10.2% 82%
OHP, nmol/L
(+ :331→109;331→97) 0.12–90.9 0.12 9.5% 92%
Both MRM channels were validated using two different LC-MS/MS instruments. LC-MS/MS - liquid chromatography coupled 
to the tandem mass spectrometry. MRM - multiple reaction monitoring. DHEAS - dehydroepiandrosterone sulfate. OHP - 
17-hydro xyprogesterone.
Analyte, unit Reagent/Manufacturer Assay range
Limit of 
quantification
Total precision, 
CV % Recovery, %
Aldosterone, nmol/L Liaison Aldosterone/DiaSorin 0.027–2.77 0.053 9.5% 91%
Cortisol, µmol/L Alinity i Cortisol/Abbott 0.028–1.650 0.028 3.7% n.a.
DHEAS, µmol/L Architect DHEA-S/Abbott 0.08–40.71 n.a. 7.41% 102%
Testosterone, nmol/L Architect 2
nd gen
Testosterone/Abbott 0.13–64.57 0.15 4.6% n.a.
Progesterone, nmol/L
Alinity i Progesterone/
Abbott 1.6–127.2 1.6 5.8% n.a.
Architect Progesterone/
Abbott n.a.–127.2 n.a. 6.2% 96%
OHP, nmol/L 17-OH-progesterone/DIAsource 0.10–60.52 n.a. n.a. 105%
DHEAS - dehydroepiandrosterone sulfate. OHP - 17-hydroxyprogesterone. n.a. = not available
Table 1. Summary of the LC-MS/MS assay validation data provided by kit manufacturer
Table 2. Summary of the immunoassay validation data provided by kit manufacturers
concentration levels for each analyte and, accept-
ance limits set to 80–120% recovery by the kit 
manufacturer, were met in each analytical se-
quence for each MRM channel. Besides the inter-
nal quality control, the system suitability parame-
ters evaluated in each analytical sequence includ-
ed also calibration regression coefficient (r) and 
ISTD coefficient of variation (CV%). For each ana-
lyte the calibration r obtained on 7 concentration 
levels was ≥ 0.99 and recoveries calculated for 
each calibration level were 80–120%. Internal 
standard CV% calculated for all samples in the an-
alytical sequence were ≤ 35% for each analyte. Fi-
nally, for the selected MRM no peak splitting or 
other sources of peak asymmetry which may indi-
cate existence of interfering substances were de-
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tected for any analyte in any of the recorded chro-
matograms.
Statistical analysis
Two approaches to immunoassay performance 
evaluation were applied (9,10). The first relies on 
the absolute bias (AB) and relative bias (RB) which 
was calculated according to Equation (Eq.) 1:
RB (%) = 
CLC – MS/MS
× 100%
CImmunoassay – CLC – MS/MS
where C stands for the serum steroid concentra-
tion measured either by a selected immunoassay 
or by the LC-MS/MS assay.
Acceptance criterion for the mean relative bias 
(RB) was set to ± 20%. This choice stems from the 
acceptance criteria for analytical accuracy that is 
recovery of LC-MS/MS assay used which is 80 - 
120%. Published desirable bias intervals for aldos-
terone, testosterone, OHP, cortisol and DHEAS are 
all narrower than 80–120%, making the chosen in-
terval quite inclusive (11). Besides the RB, mean ab-
solute bias (AB) has been calculated and graphical-
ly presented in the form of a Bland-Altman plot.
The second approach to immunoassay evaluation 
relies on the weighted Deming regression accom-
panied by the jack-knife method for 95% confi-
dence interval (CI) estimation (12). In this case, two 
acceptance criteria had to be met to reach a con-
clusion about the analytical method comparabili-
ty. These criteria involved 95%CI for slope and in-
tercept which should contain values 1 and 0, re-
spectively. Otherwise, analysed methods should 
be regarded as non-comparable. As a part of the 
regression analysis, proportional bias (PB) (%) to-
gether with the corresponding 95%CI has been es-
timated using Equation 2 (13).
PB (%) = 
CLC – MS/MS
× 100%
Intercept + (Slope – 1)CLC – MS/MS
 (Eq. 2)
Instead of a simple Deming regression, the weight-
ed version has been selected due to its robustness 
towards heteroscedasticity (12,14). For evaluating 
weighted Deming regression suitability for the an-
alytical method comparison, the Pearson correla-
tion coefficient together with the test of normality 
of standardized residuals and CUSUM test of line-
arity were conducted, both relying on the Ander-
son-Darling statistics. All calculations and graphi-
cal representations of the results were performed 
using R package for statistical computing v. 3.1.2. 
(R Foundation for Statistical Computing, Vienna, 
Austria) together with the mcr contributed pack-
age (15). If not stated otherwise, the default values 
were used for computations. P < 0.05 was consid-
ered significant.
Results
Mean relative bias and corresponding coefficients 
of variations (CV%) were calculated for all analytes 
and averaged over all samples (Table 3). Since the 
RB and its dispersion may vary along the concen-
tration axis, this assumption was tested using the 
(Eq. 1)
Analyte, unit RB% (CV%)* Linearity (P) Normality of residuals (P)
Aldosterone, nmol/L 71.22 (80.71) 0.211 0.890
Cortisol, µmol/L - 31.14 (33.39) 0.237 0.110
DHEAS, µmol/L 47.88 (58.82) 0.630 0.087
Testosterone, nmol/L 20.81 (139.61) 0.462 0.009
Progesterone, nmol/L 114.76 (139.83) 0.209 0.645
OHP, nmol/L 136.96 (55.71) 0.305 0.682
*Relative bias (RB) was averaged over the complete concentration interval and represented together with the corresponding CV%. 
P < 0.05 was considered statistically significant. DHEAS - dehydroepiandrosterone sulfate. OHP - 17-hydroxyprogesterone.
Table 3. Relative bias of analysed serum steroid immunoassays calculated against the LC-MS/MS assay and quantitative results of 
corresponding weighted Deming regression
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Figure 1. Graphical representation of immunoassay’s analytical bias estimated using the liquid chromatography coupled to the tan-
dem mass spectrometry assay (N = 49). A: Bland-Altman plots showing AB together with the corresponding trends and dispersions. 
B: Estimated PB and corresponding 95% Confidence interval (95%CI). All concentrations are given in nmol/L, except for the cortisol 
and DHEAS which are given in µmol/L. DHEAS - dehydroepiandrosterone sulphate. OHP - 17-hydroxyprogesterone.
A
B
Bland-Altman plot (Figure 1A) and plot of the PB 
(Figure 1B). The Bland-Altman plot for cortisol 
shows a descending trend in AB and negative PB, 
even at the lowest concentrations. In the OHP and 
DHEAS cases, the AB and its dispersion rise along 
the axis, while the PB decreases and then stabilizes 
along the concentration axis indicating the impor-
tant contribution of the PB to the total bias at low 
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Figure 2. Comparison of serum steroid immunoassays with liquid chromatography coupled to the tandem mass spectrometry assay 
using weighted Deming regression accompanied by jack-knife based 95% confidence interval (95%CI) estimation (N = 49). A: Regres-
sion lines with corresponding 95%CI bands (gray area). Dotted lines represent identity lines. B: Graphical presentation of slopes’ and 
intercepts’ CI’s. DHEAS - dehydroepiandrosterone sulfate. OHP - 17-hydroxyprogesterone.
A
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concentrations. In the progesterone case, both AB 
and PB change the sign along the concentration 
axis. In all other cases, the biases kept the positive 
sign. Further along, aldosterone immunoassay 
also yielded a large positive PB with decreasing 
tendency which is not stabilizing along the con-
centration axis.
Reliability of PB estimated using regression de-
pends on the same assumptions as the regression 
analysis shown in Figure 2 and Table 3. Linear rela-
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tionship between all immunoassay and LC-MS/MS 
measurements was statistically confirmed. Stand-
ardized residual’s distribution wasn’t normal only 
in the case of testosterone immunoassay, what 
may be attributed to the application of weighted 
Deming regression. This is especially important for 
the progesterone which has been determined us-
ing two different instruments interchangeably: in 
such settings, one may expect significant breach-
ing of assumptions about the linearity and the 
normality distribution of standardized residuals. 
Furthermore, Figure 2A shows a significant devia-
tion of the regression lines from identity line which 
indicates the non-comparability of analysed im-
munoassays and the LC-MS/MS assay. This is con-
firmed by results shown in the Figure 2B and Table 
3: none of the analysed immunoassays produced 
results comparable to the results produced by the 
LC-MS/MS assay.
Discussion
As shown in Tables 1 and 2, all immunoassays as 
well as the LC-MS/MS assay were validated by 
manufacturers and they, reportedly, met the vali-
dation acceptance criteria. However, our results 
show large discrepancies between all immunoas-
says and the LC-MS/MS assay. The discrepancies in 
terms of analytical bias were detected for six dif-
ferent steroid hormone concentrations assessed 
by different technologies: this provides the basis 
for some generalizations. Changes in steroid hor-
mone concentration of less than 20%, as expected 
during the hormone suppression therapy, exceed 
the steroid hormone biological variation and may 
affect the patient’s treatment (11). Although immu-
noassay recovery data, reported by the manufac-
turer, were within ± 10%, our results show biases 
larger than ± 20% for all analytes. Analytical bias 
larger than the ± 20% stems from the lack of ana-
lytical method selectivity. For the most of immu-
noassays, the PB is high in the low concentration 
range and it decreases as the actual steroid con-
centration increases. This is consistent with the ex-
pected impact of the interfering substances on 
the steroid hormone determinations: chances are 
low that the interferents would make a significant 
contribution to a result produced by the immuno-
assay if the actual steroid hormone concentration 
is high. In this case, the PB is expected to be insig-
nificant. But the interferent relative contribution to 
the result rises as the true steroid concentration 
decreases.
Considering the reported lack of selectivity, one 
might expect that immunoassays’ AB and RB 
would be positive in all cases. However, the AB and 
RB of cortisol CMIA were negative. The AB shows a 
uniform negative trend along the concentration 
axis which is consistent with the almost straight 
line accompanied by the narrow 95%CI in the PB 
plot. This pattern of the PB suggests that cortisol 
CMIA is less prone to interferences which is also 
confirmed by the CV% of the RB. Still, cortisol CMIA 
performance, either in terms of bias or in terms of 
regression features, was unsatisfactory. Negative 
bias may be associated with the materials and cali-
bration curves used for the CMIA calibration.
The only serum steroid immunoassay, besides the 
cortisol CMIA, characterized by the slope 95%CI 
entirely located in the negative region, is the pro-
gesterone CMIA. The impact of negative PB on RB 
is diminished by the predominance of samples 
coming from patients having low actual proges-
terone concentration (< 1.0 nmol/L). Progesterone 
CMIA, at least at low actual progesterone concen-
trations, yielded expected positive AB and PB. This 
resulted in the switch of AB sign near the value of 
10 nmol/L of progesterone and also in large CV% 
of RB. 
Testosterone and DHEAS CMIAs, here implement-
ed exclusively on Abbott’s Architect i2000SR, do 
not show negative biases as opposed to the assays 
implemented on Abbott’s Alinity i. Testosterone 
CMIA yielded nearly acceptable RB and was close 
to become comparable with the LC-MS/MS. De-
parture from normality of standardized regression 
residuals and the predominance of low testoster-
one (< 2.0 nmol/L) containing samples, might ex-
plain the detected differences between testoster-
one CMIA and LC-MS/MS assay. Described pattern 
of testosterone CMIA is observed in many other 
testosterone immunoassays (16). In contrast to the 
testosterone CMIA, OHP ELISA produced large RB. 
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All other parameters of method comparison were 
also beyond acceptable limits. Though to the less-
er extent, the DHEAS CMIA showed similar pattern 
as OHP ELISA, and is also characterized by the un-
acceptable RB. DHEAS immunoassay was not com-
parable to the LC-MS/MS assay, which is consistent 
with results reported by others (17). Finally, aldos-
terone CLIA represents an interesting case: al-
though the 95%CI for slope and intercept suggest-
ed that this immunoassay is nearly comparable 
with the LC-MS/MS, its RB was still too high. More-
over, aldosterone CLIA PB curve descends very 
slowly, which may indicate poor selectivity of the 
assay not only in the low concentration range. 
Problems with excessive RB are shared by some al-
dosterone radioimmunoassays (18).
Described problems with the analytical bias of se-
rum steroid immunoassays may have serious con-
sequences. In hereditary diseases of steroid me-
tabolism or in states characterized by the stimulat-
ed or autonomous steroid production, the upper 
limit of the reference interval (RI) is of the greatest 
diagnostic importance. In such settings, one may 
expect that the RB values given here are accepta-
ble at least near the upper RI limit. Testosterone, 
progesterone and cortisol CMIA may be classified 
into this category. Unfortunately, aside from corti-
sol, highly elevated concentrations of testosterone 
and progesterone are diagnostically important 
only in a limited number of conditions and treat-
ments. Cortisol CMIA represents the opposite case 
compared to testosterone and progesterone im-
munoassays: in this case falsely decreased concen-
trations are expected to affect the diagnostic per-
formance. Still, in cortisol CMIA case, the RB is al-
most constant, which enables reasonable RI ad-
justments. Even the weak request for acceptable 
RB near the upper RI limit does not hold in the 
OHP case. This analyte accumulates in blood of pa-
tients suffering from CAH, making the OHP meas-
urement important diagnostic test. Unfortunately, 
large RB characteristic for the OHP immunoassays 
can lead to false diagnoses, previously described 
by others (19,20). Large RB near the upper RI limit 
is also a characteristic of evaluated DHEAS CMIA 
(Figure 1B). It is expected that the positive RB, at 
least in some patients, affects the diagnostic eval-
uation of patients suffering from the polycystic 
ovary syndrome. The situation is more pro-
nounced at lower serum steroid concentrations. 
Apart from the cortisol CMIA, all immunoassays 
yielded large positive RB in this range. This prop-
erty should strongly discourage one to use evalu-
ated immunoassays for establishment of diagno-
ses associated with gland hypofunction or its ther-
apeutic suppression. There are number of cases 
described in literature showing the harmful effect 
of falsely elevated serum steroid concentrations 
on the patient treatment (21-23). Study of Mandić 
et al. describes the impact of exemestane therapy 
on falsely elevated serum estradiol measurement, 
while Stowasser et al. discuss the importance of 
correct aldosterone measurement in patients with 
hypertension, primary hyperaldosteronism and 
Addison disease (21,22).
Our study has two major limitations: relatively 
small number of samples and uneven distribution 
of samples per different concentration ranges for 
some steroids. However, weighted Deming regres-
sion suitability analysis has shown acceptable dis-
tribution of residuals and linear dependence of 
data, which means that the study limitations didn’t 
significantly affect at least the regression based 
analysis of bias.
In conclusion, evaluated immunoassays failed to 
satisfy requirements for methods’ comparability 
and produced significant analytical biases in re-
spect to the LC-MS/MS assay, especially at low con-
centrations. Considering the vast number of ster-
oid immunoassays of scientific and diagnostic in-
terest, studies of corresponding analytical bias 
should be continued using large, well defined sets 
of specific patient groups.
Potential conflict of interest
None declared.
Biochem Med (Zagreb) 2020;30(3):030701  https://doi.org/10.11613/BM.2020.030701 
10
Debeljak Ž. et al. Steroid immunoassay bias assessed by LC-MS/MS
References
 1. Handelsman DJ. Mass spectrometry, immunoassay and 
valid steroid measurements in reproductive medicine 
and science. Hum Reprod. 2017;32:1147–50. https://doi.
org/10.1093/humrep/dex078
 2. Wooding KM, Hankin JA, Johnson CA, Chosich JD, Baek SW, 
Bradford AP, et al. Measurement of estradiol, estrone, and 
testosterone in postmenopausal human serum by isotope 
dilution liquid chromatography tandem mass spectrometry 
without derivatization. Steroids. 2015;96:89–94. https://doi.
org/10.1016/j.steroids.2015.01.007
 3. Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, 
Ekins S. Cross-reactivity of steroid hormone immunoassays: 
Clinical significance and two-dimensional molecular simi-
larity prediction. BMC Clin Pathol. 2014;14:33. https://doi.
org/10.1186/1472-6890-14-33
 4. Valjakka J, Takkinenz K, Teerinen T, Söderlund H, Rouvi-
nen J. Structural Insights into Steroid Hormone Binding: 
The Crystal Structure of a Recombinant Anti-testostero-
ne Fab Fragment in Free and Testosterone-bound Forms. J 
Biol Chem. 2002;277:4183-90. https://doi.org/10.1074/jbc.
M105579200
 5. Nerenz RD, Jungheim E, Gronowski AM. Reproductive En-
docrinology and Related Disorders. In: Rifai N, Horvath AR, 
Wittwer CT, eds. Tietz textbook of clinical chemistry and mo-
lecular diagnostics. 6th edition. St. Louis, Missouri: Elsevier; 
2018.p.1617-53.
 6. Koal T, Shmiederer D, Pham-Tuan H, Röhring C, Rauh M. 
Standardized LC-MS/MS based steroid hormone profi-
le-analysis. J Steroid Biochem Mol Biol. 2012;129:129-38. 
https://doi.org/10.1016/j.jsbmb.2011.12.001
 7. Fanelli F, Belluomo I, Di Lallo VD, Cuomo G, De Iasio R, Bacci-
ni M, et al. Serum steroid profiling by isotopic dilution-liqu-
id chromatography-mass spectrometry: Comparison with 
current immunoassays and reference intervals in healthy 
adults. Steroids. 2011;76:244–53. https://doi.org/10.1016/j.
steroids.2010.11.005
 8. Ke Y, Bertin J, Gonthier R, Simard JN, Labrie F. A sensiti-
ve, simple and robust LC-MS/MS method for the simulta-
neous quantification of seven androgen- and estrogen-
related steroids in postmenopausal serum. J Steroid Bio-
chem Mol Biol. 2014;144:523–34. https://doi.org/10.1016/j.
jsbmb.2014.08.015
 9. Westgard JO. Basic Method Validation Third Edition. West-
gard Quality Corporation; 2008.
10.  Johnson R. Assessment of bias with emphasis on method 
comparison. Clin Biochem Rev. 2008;29 Suppl 1:S37-42. 
11.  Ricós C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Ji-
menez CV, et al. Current databases on biologic variation: 
pros, cons and progress. This database was most recently 
updated in 2014. Scand J Clin Lab Invest. 1999;59:491–500. 
https://doi.org/10.1080/00365519950185229
12.  Linnet K. Performance of Deming regression analysis in 
case of misspecified analytical error ratio in method com-
parison studies. Clin Chem. 1998;44:1024–31. https://doi.
org/10.1093/clinchem/44.5.1024
13. Danzer K. Analytical Chemistry, Theoretical and Metrologi-
cal Fundamentals; Springer, Berlin, 2007.
14.  Martin RF. General Deming regression for estimating syste-
matic bias and its confidence interval in method-com-
parison studies. Clin Chem. 2000;46:100–4. https://doi.
org/10.1093/clinchem/46.1.100
15.  R Core Team. R: A language and environment for stati-
stical computing. R Found Stat Comput Vienna, Austria. 
2013;3(1). Available at: https://www.R-project.org/. Acce-
ssed February 15th 2019.
16.  Chen Y, Yazdanpanah M, Hoffman BR, Diamandis EP, Wong 
PY. Rapid determination of serum testosterone by liquid 
chromatography-isotope dilution tandem mass spectro-
metry and a split sample comparison with three automated 
immunoassays. Clin Biochem. 2009;42:484–90. https://doi.
org/10.1016/j.clinbiochem.2008.11.009
17.  Büttler RM, Kruit A, Blankenstein MA, Heijboer AC. Measure-
ment of dehydroepiandrosterone sulphate (DHEAS): A com-
parison of isotope-dilution liquid chromatography tan-
dem mass spectrometry (id-lc-ms/ms) and seven currently 
available immunoassays. Clin Chim Acta. 2013;424:22–6. 
https://doi.org/10.1016/j.cca.2013.04.028
18.  Hinchliffe E, Carter S, Owen LJ, Keevil BG. Quantitation of 
aldosterone in human plasma by ultra high performance 
liquid chromatography tandem mass spectrometry. J Chro-
matogr B Anal Technol Biomed Life Sci. 2013;913–914:19–
23. https://doi.org/10.1016/j.jchromb.2012.11.013
19.  Ambroziak U, Kępczyńska-Nyk A, Kuryłowicz A, Małunowicz 
EM, Wõjcicka A, Miskiewicz P, et al. The diagnosis of nonc-
lassic congenital adrenal hyperplasia due to 21-hydroxyla-
se deficiency, based on serum basal or post-ACTH stimula-
tion 17-hydroxyprogesterone, can lead to false-positive di-
agnosis. Clin Endocrinol (Oxf). 2016;84:23–9. https://doi.
org/10.1111/cen.12935
20.  Fingerhut R. False positive rate in newborn screening for con-
genital adrenal hyperplasia (CAH)-ether extraction reveals 
two distinct reasons for elevated 17α-hydroxyprogesterone 
(17-OHP) values. Steroids. 2009;74:662–5. https://doi.
org/10.1016/j.steroids.2009.02.008
21.  Mandic S, Kratzsch J, Mandic D, Debeljak Z, Lukic I, Horvat 
V, et al. Falsely elevated serum oestradiol due to exemesta-
ne therapy. Ann Clin Biochem. 2017;54:402–5. https://doi.
org/10.1177/0004563216674031
22.  Stowasser M, Gordon RD. Aldosterone Assays: An Urgent 
Need for Improvement. Clin Chem. 2006;52:1640–2. https://
doi.org/10.1373/clinchem.2006.073460
23.  Marks V. False-positive Immunoassay Results: A Multicenter 
Survey of Erroneous Immunoassay Results from Assays of 74 
Analytes in 10 Donors from 66 Laboratories in Seven Coun-
tries. Clin Chem. 2002;48:2008–16. https://doi.org/10.1093/
clinchem/48.11.2008
..
